HMGB1 and head and neck cancer: In HPV-positive patients with head and neck cancers, high expression of high mobility group protein B1 (HMGB1) and anti-inflammatory cytokines may indicate immune evasion and disease recurrence and be employed as prognostic biomarkers [98].